Omeros (OMER) Stock Chart & Stock Price History → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free OMER Stock Alerts $3.36 +0.04 (+1.20%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Omeros Stock Price Performance5 Day Performance+1.36%1 Month Performance-9.68%3 Month Performance-29.71%6 Month Performance+50.67%Year-To-Date Performance+2.75%1 Year Performance-54.66% Receive OMER Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Omeros and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. OMER Stock Chart for Sunday, June, 2, 2024 OMER Chart by TradingView Omeros Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$3.32$3.36+1.20%$3.40$3.29207,765 shs$194.68 million05/30/2024$3.30$3.32+0.61%$3.39$3.30394,154 shs$192.37 million05/29/2024$3.32$3.30-0.45%$3.44$3.29193,597 shs$191.20 million05/28/2024$3.35$3.32-1.04%$3.39$3.28210,632 shs$192.07 million05/27/2024$3.35$3.35$3.37$3.30110,500 shs$194.10 million05/24/2024$3.29$3.35+1.82%$3.37$3.30110,574 shs$194.10 million Get the Latest News and Ratings for OMER and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Omeros and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$3.42$3.29-3.80%$3.43$3.29239,796 shs$190.62 million05/22/2024$3.36$3.42+1.79%$3.51$3.29208,478 shs$198.16 million05/21/2024$3.30$3.36+1.82%$3.39$3.27141,641 shs$194.68 million05/20/2024$3.45$3.30-4.35%$3.53$3.27361,231 shs$191.22 million05/17/2024$3.31$3.45+4.23%$3.57$3.28374,873 shs$199.89 million05/16/2024$4.17$3.31-20.62%$3.41$3.001.21 million shs$191.80 million05/15/2024$4.20$4.17-0.71%$4.34$4.08451,738 shs$241.61 million05/14/2024$3.75$4.20+12.00%$4.21$3.79512,242 shs$243.35 million05/13/2024$3.51$3.75+6.84%$3.75$3.50138,294 shs$217.28 million05/10/2024$3.56$3.51-1.40%$3.60$3.37198,183 shs$203.37 million05/09/2024$3.53$3.56+0.85%$3.62$3.32146,524 shs$206.27 million05/08/2024$3.64$3.53-3.02%$3.70$3.51166,363 shs$204.53 million05/07/2024$3.67$3.64-0.82%$3.74$3.63147,714 shs$210.90 million05/06/2024$3.73$3.67-1.61%$3.92$3.64178,142 shs$212.65 million05/03/2024$3.72$3.73+0.27%$3.84$3.61158,315 shs$216.12 million05/02/2024$3.40$3.72+9.41%$3.73$3.38275,383 shs$215.54 million05/01/2024$3.15$3.40+7.94%$3.48$3.16250,751 shs$197.01 million04/30/2024$3.13$3.15+0.64%$3.19$3.07172,115 shs$182.51 million04/29/2024$3.15$3.13-0.63%$3.31$3.11197,438 shs$181.35 million04/26/2024$3.06$3.15+2.94%$3.18$3.07172,886 shs$182.51 million04/25/2024$3.04$3.06+0.66%$3.10$2.97265,792 shs$177.30 million04/24/2024$3.09$3.04-1.62%$3.12$3.03245,102 shs$176.14 million04/23/2024$3.08$3.09+0.32%$3.25$3.07210,628 shs$179.04 million04/22/2024$3.05$3.08+0.98%$3.16$3.00291,621 shs$178.46 million04/19/2024$3.21$3.05-4.98%$3.25$3.03385,937 shs$176.72 million04/18/2024$3.34$3.21-3.89%$3.41$3.20429,130 shs$185.99 million04/17/2024$3.43$3.34-2.62%$3.57$3.32269,394 shs$193.53 million04/16/2024$3.38$3.43+1.48%$3.48$3.28237,162 shs$198.73 million04/15/2024$3.76$3.38-10.11%$3.82$3.36429,470 shs$195.84 million04/12/2024$3.94$3.76-4.57%$4.10$3.72304,695 shs$217.85 million04/11/2024$3.64$3.94+8.24%$3.97$3.62531,029 shs$228.28 million04/10/2024$3.43$3.64+6.12%$3.66$3.31475,210 shs$210.90 million04/09/2024$3.42$3.43+0.29%$3.59$3.38327,984 shs$198.73 million04/08/2024$3.43$3.42-0.29%$3.67$3.39502,384 shs$198.16 millionBiotech's Best Kept Secret: Potential 46,751% Gain (Ad)The world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>>04/05/2024$3.12$3.43+9.94%$3.47$3.11440,837 shs$198.73 million04/04/2024$3.15$3.12-0.95%$3.35$3.10491,201 shs$196.15 million04/03/2024$3.05$3.15+3.28%$3.21$3.00332,799 shs$198.03 million04/02/2024$3.19$3.05-4.39%$3.10$2.611.11 million shs$191.75 million04/01/2024$3.45$3.19-7.54%$3.41$3.08548,783 shs$200.56 million03/29/2024$3.45$3.45$3.51$3.36332,863 shs$216.90 million03/28/2024$3.42$3.45+0.88%$3.51$3.36331,192 shs$216.90 million03/27/2024$3.46$3.42-1.16%$3.56$3.36238,013 shs$215.02 million03/26/2024$3.44$3.46+0.58%$3.58$3.40192,595 shs$217.53 million03/25/2024$3.40$3.44+1.18%$3.52$3.34281,180 shs$216.27 million03/22/2024$3.67$3.40-7.36%$3.65$3.40396,978 shs$213.76 million03/21/2024$3.77$3.67-2.65%$3.94$3.66320,156 shs$230.73 million03/20/2024$3.59$3.77+5.01%$3.81$3.53271,176 shs$237.02 million03/19/2024$3.52$3.59+1.99%$3.70$3.49300,326 shs$225.70 million03/18/2024$3.65$3.52-3.56%$3.67$3.36601,180 shs$221.30 million03/15/2024$3.68$3.65-0.82%$3.82$3.60557,098 shs$229.48 million03/14/2024$4.04$3.68-8.91%$4.04$3.661.10 million shs$231.34 million03/13/2024$4.03$4.04+0.25%$4.19$4.01361,957 shs$253.98 million03/12/2024$4.20$4.03-4.05%$4.21$4.02314,231 shs$253.37 million03/11/2024$4.38$4.20-4.11%$4.43$4.18326,607 shs$264.05 million03/08/2024$4.52$4.38-3.10%$4.70$4.32442,861 shs$275.37 million03/07/2024$4.41$4.52+2.49%$4.60$4.36292,642 shs$284.17 million03/06/2024$4.21$4.41+4.75%$4.60$4.16565,618 shs$277.26 million03/05/2024$4.44$4.21-5.18%$4.47$4.19326,778 shs$264.68 million03/04/2024$4.78$4.44-7.11%$4.85$4.23596,399 shs$279.12 million03/01/2024$4.50$4.78+6.22%$4.85$4.48436,748 shs$300.52 million Related Companies: NKTR Stock Price Chart VNDA Stock Price Chart ASMB Stock Price Chart CARA Stock Price Chart CPIX Stock Price Chart ESPR Stock Price Chart RDUS Stock Price Chart CALT Stock Price Chart MNKD Stock Price Chart LLY Stock Price Chart Receive OMER Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Omeros and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OMER) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTradeThe #1 Crypto That You Don’t Own… YetCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omeros Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.